$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years, producing an average annual return of 28.39%. If an investor had bought $100 of REGN stock 15 years ago, it would be worth $3,936.62 today. The company currently has a market capitalization of $84.49 billion.
October 31, 2023 | 5:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown strong performance over the past 15 years, with an average annual return of 28.39%. This historical performance may attract investors.
The news highlights the strong historical performance of Regeneron Pharmaceuticals, which has outperformed the market over the past 15 years. This could potentially attract more investors to the stock, driving up its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100